SORIA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 2.647
EU - Europa 1.298
AS - Asia 296
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 4.266
Nazione #
US - Stati Uniti d'America 2.610
IT - Italia 305
DE - Germania 283
SE - Svezia 249
IE - Irlanda 200
CN - Cina 129
HK - Hong Kong 70
GB - Regno Unito 59
UA - Ucraina 56
CA - Canada 36
IN - India 34
DK - Danimarca 30
AT - Austria 28
FI - Finlandia 24
VN - Vietnam 21
RU - Federazione Russa 16
SG - Singapore 16
TR - Turchia 14
BE - Belgio 13
FR - Francia 12
CO - Colombia 11
NL - Olanda 7
IR - Iran 6
PL - Polonia 5
CL - Cile 4
EU - Europa 4
CH - Svizzera 3
JP - Giappone 3
PH - Filippine 3
AU - Australia 2
BR - Brasile 2
GR - Grecia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
JM - Giamaica 1
LT - Lituania 1
RO - Romania 1
Totale 4.266
Città #
Ann Arbor 894
Chandler 244
Frankfurt am Main 244
Fairfield 225
Dublin 197
Wilmington 146
New York 116
Woodbridge 111
Ashburn 108
Houston 107
Seattle 84
Cambridge 70
Hong Kong 70
Princeton 70
Milan 52
Jacksonville 48
Altamura 37
Dearborn 36
Lawrence 32
Vienna 26
Shanghai 24
Pune 19
Nanjing 18
Andover 17
Fremont 17
Guangzhou 17
London 16
Boardman 15
Dong Ket 14
Ottawa 13
Brussels 12
Rome 12
San Diego 12
Helsinki 11
Bogotá 9
Lachine 9
Los Angeles 9
Falls Church 8
Shenyang 8
Changsha 7
Hebei 7
Lissone 7
Nanchang 6
Toronto 6
Bresso 5
Edmonton 5
Jinan 5
Kiev 5
Monza 5
Palermo 5
Rovereto 5
Washington 5
Beijing 4
Brescia 4
Enterprise 4
Ningbo 4
Polska 4
Turin 4
Carate Brianza 3
Catania 3
Hangzhou 3
Hanoi 3
Kocaeli 3
Maastricht 3
Santiago 3
Stockholm 3
Taizhou 3
Weimar 3
Altamonte Springs 2
Amsterdam 2
Bangalore 2
Bari 2
Bergamo 2
Bhubaneswar 2
Broni 2
Ceva 2
Changchun 2
Chelyabinsk 2
Chengdu 2
Chennai 2
Chennevières-sur-marne 2
Chicago 2
Chiswick 2
Clearwater 2
Florence 2
Garbagnate Milanese 2
Hyderabad 2
Jiaxing 2
Kunming 2
Lanzhou 2
Lappeenranta 2
Leawood 2
Loreto 2
Norwalk 2
Novokuznetsk 2
Obolon 2
Olbia 2
Paris 2
Paullo 2
Recanati 2
Totale 3.368
Nome #
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 298
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 224
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 210
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 201
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 193
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 185
HIV testing: A must for patients with inflammatory bowel disease 181
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 175
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 173
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 168
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 161
High rates of 30-day mortality in patients with cirrhosis and COVID-19 155
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 154
Unmasking tuberculosis in the era of antiretroviral treatment 152
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 152
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 151
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 151
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 149
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 139
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 116
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 107
Beware of biases in observational studies on anti-spike monoclonal antibodies 86
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 84
Malassorbimento intestinale della terapia antiretrovirale in un paziente affetto da AIDS e micobatteriosi atipica disseminata 83
COVID-19 Mortality and Stress to the Hospital System From High Patient Load 82
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 67
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 59
Pharmacotherapy of HIV: Focus on Etravirine 58
Unmasked tuberculosis or lymphoma in late AIDS presenters: A difficult differential diagnosis 58
Imported ciprofloxacin-resistant Neisseria meningitidis 57
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 52
Unexpected viral relapses in hepatitis C virus–infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals 47
Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo study 43
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 41
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 33
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 33
COVID-19 Infection among Incarcerated Individuals and Prison Staff in Lombardy, Italy, March 2020 to February 2021 16
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 10
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition 6
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 3
Totale 4.513
Categoria #
all - tutte 14.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.868


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019124 0 0 0 0 0 0 0 0 0 0 52 72
2019/2020505 50 31 35 28 29 49 46 32 62 47 53 43
2020/20211.042 37 49 70 120 120 90 73 100 93 109 63 118
2021/2022777 89 95 125 80 33 73 8 33 18 59 60 104
2022/20231.042 107 310 106 97 52 151 17 74 63 9 38 18
2023/2024642 26 18 30 24 100 222 126 34 36 19 7 0
Totale 4.513